Brought to you by:

Proxygen

Proxygen develops molecular glue degraders for cancer and other life-threatening diseases.

Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f
Biotech

Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders

Bayer radiology head takes top U.S. pharma spot. Restructuring Evotec taps AI vet as commercial chief. Cue lines up interim CEO.
cash runway cash airplane extend deal earnings

Proxygen inks $2.5B deal with Merck & Co. as collabs stack up

Apr 5, 2023 7:00am
visual of targeted protein degradation

Merck KGaA nabs another teammate in protein degradation race

Jun 2, 2022 11:00am